Fig. 2From: MicroRNA-382 inhibits cell growth and migration in colorectal cancer by targeting SP1CRC patients with low MIR-382 expression had a significantly shorter 5-year overall survival than those with high MIR-382 expression. MIR-382: microRNA-382; CRC: colorectal cancerBack to article page